false
OasisLMS
Catalog
SCCM Resource Library
Year in Review: Neuroscience: Pharmacology Researc ...
Year in Review: Neuroscience: Pharmacology Research Update 1
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The speaker discusses recent advances and studies in neuroscience pharmacology, focusing on ischemic stroke, anticoagulation, and bleeding management. Key studies include the ELAN study, which evaluates the timing of direct oral anticoagulant (DOAC) initiation after ischemic stroke with atrial fibrillation, finding early initiation can be as effective as later starts. The DOAC IVT study shows DOAC intake preceding IV thrombolysis doesn't significantly increase intracranial hemorrhage risk. The DEXA trial compares corticosteroids and surgical intervention for chronic subdural hematoma, favoring surgery due to better outcomes. RESQ-BT2 evaluates tirofiban versus aspirin for acute stroke patients ineligible for other therapies, showing better functional outcomes but increased hemorrhagic risk. The talk highlights guidelines and additional studies, including the TWIST trial for tenecteplase in wake-up strokes and evaluations of tranexamic acid and desmopressin for hemorrhage management, underscoring the evolving approach to stroke and hemorrhage treatment.
Asset Caption
Year in Review | Year in Review: Neuroscience
Meta Tag
Content Type
Presentation
Membership Level
Professional
Membership Level
Select
Year
2024
Keywords
neuroscience pharmacology
ischemic stroke
anticoagulation
DOAC initiation
hemorrhage management
stroke treatment
×
Please select your language
1
English